analysis
Novo Nordisk Just Bet The Pharma House On OpenAI: April 14, 2026 Six-Domain AI Integration Decoded
On April 14, 2026, Novo Nordisk — the world's largest pharma by market cap — signed a six-domain AI integration with OpenAI: drug discovery, clinical trials, manufacturing, supply chain, commercial, corporate functions. Full integration end 2026.